Funding Rounds
Tubulis Therapeutics

Tubulis Series B round, May 2022

Tubulis Therapeutics

Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $63.00M

Raised Date: 2022-05-03

Investors